Preventive maintenance and repair service for BD facscanto II flow cytometer , s/n: V96100162

Ended Awarded Last action

Contract number
75F40121F80148
Awardee
Awarding agency
Obligated
$52,461

Award facts

Contract value 80% obligated
  • $52,461.12 Current, with exercised options
  • $65,576.40 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20993, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00006 $0
Terminate for Convenience P00005 · EOI:: implementing the president's "department of government efficiency" cost efficiency initiative :: EOI notice of termination for convenience $0
Exercise an Option P00004 $13,115
Exercise an Option P00003 $13,115
Exercise an Option P00002 $13,115
Other Administrative Action P00001 $0
Original award $13,115

About this award

This delivery order, awarded May 13, 2021, to Becton, Dickinson and Company (BD Biosciences division) by the Food and Drug Administration, provides preventive maintenance and repair services for a BD FACSCanto II Flow Cytometer (Serial Number V96100162) located at the FDA's Silver Spring, Maryland facility. The contract is structured as a firm fixed-price delivery order with a ceiling value of $65,576.40 and ultimate completion date of March 12, 2025. The award was issued under the Multiple Award Schedule vehicle without a small business set-aside. BD Biosciences, a global medical technology manufacturer, is a qualified supplier of flow cytometry systems and associated maintenance services to multiple federal agencies, including the Department of Veterans Affairs, National Institutes of Health, Centers for Disease Control and Prevention, and Defense Health Agency.

The contract has been terminated for convenience effective immediately as part of the implementation of the President's Department of Government Efficiency cost efficiency initiative. BD Biosciences maintains extensive indefinite delivery vehicle agreements across federal agencies valued at over $7.7 million collectively, supporting the company's role as a strategic supplier of specialized laboratory instrumentation essential to biomedical research and clinical diagnostics operations within the federal healthcare and research enterprise.

Quick answers

Who was awarded contract 75F40121F80148?

75F40121F80148 was awarded to Becton, Dickinson And Company by Food and Drug Administration (Department of Health and Human Services) on May 13, 2021.

How much is contract 75F40121F80148 worth?

The government has obligated $52,461 on 75F40121F80148. Its potential value, with all options, is $65,576.

Is contract 75F40121F80148 an order under another contract?

Yes. 75F40121F80148 is a delivery order under GS07F195DA, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract 75F40121F80148 competed?

The extent of competition for 75F40121F80148 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award